The average estimate of four analysts surveyed by Zacks Investment Research was for funds from operations of $1.10 per share. Funds from operations is a closely watched measure in the REIT industry.
There’s a lot to be optimistic about in the Real Estate sector as 3 analysts just weighed in on LTC Properties (LTC – Research Report), ...
MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. (NYSE:NHI) has issued the following ...
MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 ...
14h
Zacks.com on MSNNational Health Investors (NHI) Tops Q4 FFO and Revenue EstimatesNational Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.13 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to FFO of $1.09 per share ...
MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and twelve months ended December 31, 2024.Financial Result ...
12h
Zacks.com on MSNNational Health Investors (NHI) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesNational Health Investors (NHI) reported $85.75 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 7.9%. EPS of $1.13 for the same period compares to $0.
The Trump administration’s plans to reduce National Institutes of Health grant funding could have long-term consequences for the U.S. drug industry, investors said.
SCOs generally include high streets, hypermarkets, offices, retail units, co-working spaces, restaurants, cafes and the like.
State of New Jersey Common Pension Fund D grew its position in Select Medical Holdings Co. (NYSE:SEM – Free Report) by 2.2% during the 4th quarter, Holdings Channel reports. The fund owned 56,719 ...
-- Effective 1 April 2025, Austrian Reimbursement Marks 10th National Reimbursement for VAZKEPA® in Europe, Supporting Amarin's Continued Growth and Development Across the Continent -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results